# Mynd.ai, Inc.: financial statements, quarterly

MYND · NYSE · CIK 1708441 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mynd.md) · [Financials](/companies/mynd/financials.md) · [Filings](/companies/mynd/filings.md) · [Insiders](/companies/mynd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mynd/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | [46.3](/filings/0001104659-18-026323.md) | [159](/filings/0001104659-19-023854.md) | [104](/filings/0001104659-20-053868.md) | [68.7](/filings/0001104659-21-066849.md) | [53.5](/filings/0001104659-22-058841.md) | [33.3](/filings/0001104659-23-052982.md) | [29.3](/filings/0001628280-24-013188.md) | [87.8](/filings/0001628280-25-014832.md) | [75.3](/filings/0001708441-26-000055.md) | [18.5](/filings/0001708441-26-000055.md) |
| Current assets | $m | not reported | not reported | [64.0](/filings/0001104659-18-026323.md) | [173](/filings/0001104659-19-023854.md) | [122](/filings/0001104659-20-053868.md) | [91.6](/filings/0001104659-21-066849.md) | [70.1](/filings/0001104659-22-058841.md) | [82.3](/filings/0001104659-23-052982.md) | [228](/filings/0001628280-24-013188.md) | [227](/filings/0001628280-25-014832.md) | [148](/filings/0001708441-26-000055.md) | [84.1](/filings/0001708441-26-000055.md) |
| Total assets | $m | not reported | not reported | [104](/filings/0001104659-18-026323.md) | [230](/filings/0001104659-19-023854.md) | [243](/filings/0001104659-20-053868.md) | [336](/filings/0001104659-21-066849.md) | [302](/filings/0001104659-22-058841.md) | [283](/filings/0001104659-23-052982.md) | [369](/filings/0001628280-24-013188.md) | [407](/filings/0001628280-25-014832.md) | [253](/filings/0001708441-26-000055.md) | [183](/filings/0001708441-26-000055.md) |
| Current liabilities | $m | not reported | not reported | [80.3](/filings/0001104659-18-026323.md) | [97.0](/filings/0001104659-19-023854.md) | [108](/filings/0001104659-20-053868.md) | [126](/filings/0001104659-21-066849.md) | [128](/filings/0001104659-22-058841.md) | [122](/filings/0001104659-23-052982.md) | [207](/filings/0001628280-24-013188.md) | [186](/filings/0001628280-25-014832.md) | [130](/filings/0001708441-26-000055.md) | [110](/filings/0001708441-26-000055.md) |
| Total liabilities | $m | not reported | not reported | [100](/filings/0001104659-18-026323.md) | [124](/filings/0001104659-19-023854.md) | [128](/filings/0001104659-20-053868.md) | [219](/filings/0001104659-21-066849.md) | [225](/filings/0001104659-22-058841.md) | [204](/filings/0001104659-23-052982.md) | [232](/filings/0001628280-24-013188.md) | [286](/filings/0001628280-25-014832.md) | [224](/filings/0001708441-26-000055.md) | [200](/filings/0001708441-26-000055.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [52.8](/filings/0001628280-24-013188.md) | [64.9](/filings/0001628280-25-014832.md) | [58.1](/filings/0001708441-26-000055.md) | [61.1](/filings/0001708441-26-000055.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001104659-21-066849.md) | [0.0](/filings/0001104659-22-058841.md) | not reported | [48.0](/filings/0001628280-24-013188.md) | [31.9](/filings/0001628280-25-014832.md) | [10.9](/filings/0001708441-26-000055.md) | [2.9](/filings/0001708441-26-000055.md) |
| Shareholders' equity | $m | [(34.4)](/filings/0001104659-18-026323.md) | [(3.2)](/filings/0001104659-19-023854.md) | [3.5](/filings/0001104659-18-026323.md) | [104](/filings/0001104659-19-023854.md) | [109](/filings/0001104659-20-053868.md) | [98.5](/filings/0001104659-21-066849.md) | [62.1](/filings/0001104659-22-058841.md) | [67.7](/filings/0001104659-23-052982.md) | [137](/filings/0001628280-24-013188.md) | [119](/filings/0001628280-25-014832.md) | [28.4](/filings/0001708441-26-000055.md) | [(17.5)](/filings/0001708441-26-000055.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

Shares outstanding: 462,192,400 at 2025-12-31, from the cover of the [20-F filed 2026-05-29](/filings/0001708441-26-000055.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.